Carlton Hofferkamp & Jenks Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Carlton Hofferkamp & Jenks Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,879	Closed	-$317K	–	144
2025 Q4	$317K	Hold	5,879	–	–	0.11%	109
2025 Q3	$255K	Sell	5,879 -300	-5%	-$14K	0.09%	124
2025 Q2	$284K	Hold	6,179	–	–	0.1%	116
2025 Q1	$305K	Sell	6,179 -73	-1%	-$4.25K	0.13%	108
2024 Q4	$373K	Hold	6,252	–	–	0.14%	106
2024 Q3	$347K	Hold	6,252	–	–	0.13%	109
2024 Q2	$307K	Hold	6,252	–	–	0.12%	112
2024 Q1	$279K	Hold	6,252	–	–	0.12%	111
2023 Q4	$314K	Sell	6,252 -1,000	-14%	-$52.5K	0.13%	105
2023 Q3	$411K	Sell	7,252 -150	-2%	-$9.19K	0.19%	90
2023 Q2	$448K	Hold	7,402	–	–	0.2%	90
2023 Q1	$507K	Buy	7,402 +73	+1%	+$5.15K	0.23%	89
2022 Q4	$531K	Hold	7,329	–	–	0.23%	89
2022 Q3	$529K	Hold	7,329	–	–	0.25%	89
2022 Q2	$552K	Hold	7,329	–	–	0.25%	87
2022 Q1	$570K	Hold	7,329	–	–	0.23%	90
2021 Q4	$458K	Buy	7,329 +150	+2%	+$8.8K	0.19%	95
2021 Q3	$427K	Hold	7,179	–	–	0.17%	101
2021 Q2	$483K	Buy	7,179 +184	+3%	+$12K	0.21%	93
2021 Q1	$461K	Buy	6,995 +95	+1%	+$5.91K	0.21%	89
2020 Q4	$461K	Hold	6,900	–	–	0.23%	86
2020 Q3	$438K	Buy	6,900 +500	+8%	+$30.1K	0.23%	85
2020 Q2	$379K	Hold	6,400	–	–	0.22%	79
2020 Q1	$394K	Sell	6,400 -1,600	-20%	-$97.8K	0.24%	78
2019 Q4	$510K	Buy	8,000 +400	+5%	+$22.9K	0.29%	75
2019 Q3	$386K	Hold	7,600	–	–	0.24%	77
2019 Q2	$335K	Hold	7,600	–	–	0.2%	79
2019 Q1	$363K	Hold	7,600	–	–	0.23%	74
2018 Q4	$395K	Sell	7,600 -1,300	-15%	-$69.8K	0.28%	68
2018 Q3	$552K	Hold	8,900	–	–	0.34%	66
2018 Q2	$488K	Hold	8,900	–	–	0.31%	69
2018 Q1	$556K	Hold	8,900	–	–	0.37%	61
2017 Q4	$545K	Hold	8,900	–	–	0.34%	66
2017 Q3	$567K	Hold	8,900	–	–	0.36%	64
2017 Q2	$495K	Buy	8,900 +1,000	+13%	+$54.4K	0.34%	63
2017 Q1	$429K	Hold	7,900	–	–	0.3%	67
2016 Q4	$461K	Buy	7,900 +1,800	+30%	+$98.4K	0.34%	58
2016 Q3	$328K	Buy	6,100 +2,100	+53%	+$135K	0.26%	70
2016 Q2	$294K	Sell	4,000 -23,743	-86%	-$1.68M	0.23%	70
2016 Q1	$1.77M	Buy	27,743 +763	+3%	+$48.1K	1.45%	19
2015 Q4	$1.81M	Sell	26,980 -825	-3%	-$54.5K	1.55%	19
2015 Q3	$1.65M	Buy	27,805 +703	+3%	+$44.6K	1.6%	21
2015 Q2	$1.83M	Buy	27,102 +509	+2%	+$33.5K	1.71%	18
2015 Q1	$1.72M	Sell	26,593 -25	-0.1%	-$1.56K	1.71%	17
2014 Q4	$1.57M	Buy	26,618 +626	+2%	+$35.3K	1.39%	18
2014 Q3	$1.31M	Buy	25,992 +1,200	+5%	+$59.9K	1.5%	26
2014 Q2	$1.2M	Buy	24,792 +8,811	+55%	+$434K	1.55%	24
2014 Q1	$830K	Buy	15,981 +1,050	+7%	+$55.9K	1.08%	32
2013 Q4	$793K	Sell	14,931 -3,574	-19%	-$182K	1.12%	28
2013 Q3	$856K	Buy	18,505 +159	+0.9%	+$6.98K	1.37%	25
2013 Q2	$819K	Buy	+18,346	New	+$796K	1.31%	25

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Carlton Hofferkamp & Jenks Wealth Management's BMY Position: Q1 2026 in Review

Carlton Hofferkamp & Jenks Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 5,879 shares — an estimated $317K sold.

Carlton Hofferkamp & Jenks Wealth Management first reported a position in BMY in Q2 2013 and held it in 51 quarters. The position peaked at $1.83M in Q2 2015. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Carlton Hofferkamp & Jenks Wealth Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
Carlton Hofferkamp & Jenks Wealth Management sold 5,879 Bristol-Myers Squibb shares in Q1 2026, an estimated $317K.
Carlton Hofferkamp & Jenks Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 51 quarters.
Carlton Hofferkamp & Jenks Wealth Management's Bristol-Myers Squibb position peaked at $1.83M in Q2 2015.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Carlton Hofferkamp & Jenks Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.